Z
ZURA BIO LIMITED CLASS A ORDINARY SHARES
NASDAQ: ZURA (Zura Bio Limited)
Kemas kini terakhir: 2 hari lalu, 2:17AM3.74
-0.15 (-3.86%)
| Penutupan Terdahulu | 3.89 |
| Buka | 3.91 |
| Jumlah Dagangan | 223,402 |
| Purata Dagangan (3B) | 1,658,263 |
| Modal Pasaran | 243,187,168 |
| Harga / Buku (P/B) | 2.11 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 13 Nov 2025 |
| EPS Cair (TTM) | -0.770 |
| Nisbah Semasa (MRQ) | 8.14 |
| Aliran Tunai Operasi (OCF TTM) | -34.16 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -17.40 M |
| Pulangan Atas Aset (ROA TTM) | -31.40% |
| Pulangan Atas Ekuiti (ROE TTM) | -55.05% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Zura Bio Limited | Menaik | Menaik |
AISkor Stockmoo
0.3
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | -0.5 |
| Purata | 0.25 |
|
Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 29.16% |
| % Dimiliki oleh Institusi | 70.62% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 18.00 (Clear Street, 381.28%) | Beli |
| Median | 14.00 (274.33%) | |
| Rendah | 10.00 (Chardan Capital, 167.38%) | Beli |
| Purata | 14.00 (274.33%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 4.13 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Chardan Capital | 14 Nov 2025 | 10.00 (167.38%) | Beli | 4.08 |
| 30 Sep 2025 | 10.00 (167.38%) | Beli | 4.33 | |
| Clear Street | 13 Nov 2025 | 18.00 (381.28%) | Beli | 4.18 |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 13 Nov 2025 | Pengumuman | Zura Bio Reports Third Quarter 2025 Financial Results and Recent Corporate Updates |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |